Skip to content

DWI MR imaging for dedicated staging of patients with peritoneal seeding.

DWI MR imaging for dedicated staging of patients with peritoneal seeding. - DISPERSE

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON43419
Enrollment
20
Registered
2016-05-25
Start date
2016-04-01
Completion date
Unknown
Last updated
2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

peritoneal carcinomatosis

Interventions

None listed

Sponsors

The Netherlands Cancer Institute
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Patients already scheduled for cytoreductive surgery +/- HIPEC procedure with histology proven colorectal or ovarian cancer - Age >18 years - Written informed consent

Exclusion criteria

Exclusion criteria: - contraindication for MRI (metal) or MRI contrast agent (Gadolinium) - contraindicaties for Buscopan - allergie voor ananassap - age

Design outcomes

Primary

MeasureTime frame
- Prediction of PCI with DWI MRI, using the surgically determined PCI as the reference standard.

Secondary

MeasureTime frame
- MR Scan quality; good / moderate / poor - Comparison of the diagnostic performance of DWI-MRI in assessing the PCI with the results of CT (=common practice) in colorectal cancer patients.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)